ArticleJournal of clinical medicine2022

Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study.

Rabea Asleh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.